$383 Million is the total value of BOONE CAPITAL MANAGEMENT LLC's 19 reported holdings in Q2 2024. The portfolio turnover from Q1 2024 to Q2 2024 was 38.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UNM | Sell | UNUM GROUP | $47,560,155 | -13.5% | 930,545 | -9.2% | 12.40% | +11.5% |
| GMED | Buy | GLOBUS MED INCcl a | $43,649,704 | +53.6% | 637,315 | +20.3% | 11.38% | +98.1% |
| CI | THE CIGNA GROUP | $43,610,778 | -9.0% | 131,926 | 0.0% | 11.38% | +17.4% | |
| MOH | Buy | MOLINA HEALTHCARE INC | $29,460,646 | -16.3% | 99,094 | +15.6% | 7.68% | +7.9% |
| DHR | Buy | DANAHER CORPORATION | $26,574,046 | +61.7% | 106,360 | +61.6% | 6.93% | +108.5% |
| BAX | Buy | BAXTER INTL INC | $24,126,749 | -19.1% | 721,278 | +3.3% | 6.29% | +4.3% |
| IQV | New | IQVIA HLDGS INC | $20,030,557 | – | 94,734 | +100.0% | 5.22% | – |
| AMPH | Sell | AMPHASTAR PHARMACEUTICALS IN | $19,803,560 | -25.7% | 495,089 | -18.4% | 5.16% | -4.1% |
| MIRM | Buy | MIRUM PHARMACEUTICALS INC | $17,904,585 | +57.7% | 523,679 | +15.9% | 4.67% | +103.4% |
| PNTG | Buy | PENNANT GROUP INC | $16,232,212 | +46.6% | 699,966 | +24.1% | 4.23% | +89.0% |
| BERY | Sell | BERRY GLOBAL GROUP INC | $15,283,934 | -43.9% | 259,710 | -42.3% | 3.99% | -27.6% |
| IDYA | Sell | IDEAYA BIOSCIENCES INC | $14,818,140 | -36.5% | 422,049 | -20.7% | 3.86% | -18.1% |
| OFIX | Sell | ORTHOFIX MED INC | $10,281,380 | -27.3% | 775,368 | -20.4% | 2.68% | -6.3% |
| CRL | New | CHARLES RIV LABS INTL INC | $9,975,335 | – | 48,288 | +100.0% | 2.60% | – |
| CERT | New | CERTARA INC | $9,957,915 | – | 718,983 | +100.0% | 2.60% | – |
| XENE | Sell | XENON PHARMACEUTICALS INC | $9,765,435 | -22.2% | 250,460 | -14.1% | 2.55% | +0.4% |
| VKTX | Sell | VIKING THERAPEUTICS INC | $9,264,346 | -63.6% | 174,766 | -43.7% | 2.42% | -53.1% |
| HCSG | Sell | HEALTHCARE SVCS GROUP INC | $9,236,530 | -20.1% | 873,018 | -5.8% | 2.41% | +3.0% |
| TARS | Sell | TARSUS PHARMACEUTICALS INC | $5,872,157 | -73.5% | 216,047 | -64.5% | 1.53% | -65.8% |
| QTRX | Exit | QUANTERIX CORP | $0 | – | -330,151 | -100.0% | -1.57% | – |
| VTRS | Exit | VIATRIS INC | $0 | – | -1,133,591 | -100.0% | -2.74% | – |
| MLAB | Exit | MESA LABS INC | $0 | – | -133,394 | -100.0% | -2.96% | – |
| BIO | Exit | BIO RAD LABS INCcl a | $0 | – | -72,344 | -100.0% | -5.06% | – |
| Exit | ENOVIS CORPORATION | $0 | – | -562,739 | -100.0% | -7.11% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNUM GROUP | 7 | Q2 2024 | 15.9% |
| THE CIGNA GROUP | 7 | Q2 2024 | 12.3% |
| MOLINA HEALTHCARE INC | 7 | Q2 2024 | 11.7% |
| DANAHER CORPORATION | 7 | Q2 2024 | 10.4% |
| ENOVIS CORPORATION | 6 | Q1 2024 | 9.8% |
| BAXTER INTL INC | 6 | Q2 2024 | 11.2% |
| QUANTERIX CORP | 6 | Q1 2024 | 4.9% |
| IDEAYA BIOSCIENCES INC | 5 | Q2 2024 | 4.9% |
| AMGEN INC | 4 | Q4 2023 | 9.0% |
| GLOBUS MED INC | 4 | Q2 2024 | 11.4% |
View BOONE CAPITAL MANAGEMENT LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
View BOONE CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.